The impact of new drug launches on longevity: Evidence from longitudinal, disease-level data from 52 countries, 1982-2001

International Journal of Health Care Finance and Economics

Volumn 5, Issue 1, 2005, Pages 47-73

  Lichtenberg, Frank R ^a  

^a The Sanford C Bernstein Co Center for Leadership and Ethics   (United States)

Author keywords

Cost effectiveness; Innovation; Life expectancy; Longevity; Mortality; Pharmaceuticals

Indexed keywords

DRUG;

ARTICLE; DRUG APPROVAL; DRUG EFFECT; DRUG INDUSTRY; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH; HEALTH SERVICES RESEARCH; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LIFE EXPECTANCY; LIFE TABLE; LONGEVITY; MASS COMMUNICATION; PROBABILITY; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; SURVIVAL;

DIFFUSION OF INNOVATION; DRUG APPROVAL; DRUG INDUSTRY; HEALTH SERVICES RESEARCH; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LIFE EXPECTANCY; LIFE TABLES; LONGEVITY; MODELS, ECONOMETRIC; PHARMACEUTICAL PREPARATIONS; PROBABILITY; RESEARCH SUPPORT; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; WORLD HEALTH;

EID: 14044276281     PISSN: 13896563     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10754-005-6601-7     Document Type: Article

References (26)

1. Agency for Healthcare Research and Quality (2002). "MEPS H38Codebook: 1999 Full Year Consolidated Data File Codebook." November 27, http://www.meps.ahrq.gov/Pubdoc/HC038/H38CB.pdf
2. Arias, E. (2002). "United States Life Tables, 2000." National Vital Statistics Reports 51(3). (Hyattsville, MD: National Center for Health Statistics).
3. Ernst Berndt Margaret K. Kyle Davina Ling 2003 "The Long Shadow of Patent Expiration: Do Rx to OTC Switches Provide an Afterlife?" In Robert C. Feenstra Matthew D. Shapiro (Eds) Scanner Data and Price Indexes University of Chicago Press Chicago
4. T. Bresnahan R. Gordon 1997 The Economics of New Goods University of Chicago Press Chicago
5. Cutler, D. and M. McClellan (2001). "Is Technological Change in Medicine Worth It?" Health Affairs 20(5), 11-29.
6. Danzon, P., Y. R. Wang, and L. Wang (2003). "The Impact of Price Regulation on the Launch Delay of New Drugs - A Study of Twenty-Five Major Markets in the 1990s." http://hc.wharton.upenn.edu/danzon/ PDFFiles/LaunchDelayPaper.pdf.
7. S. Folland A. Goodman M. Stano 2001 The Economics of Health and Health Care third edition Prentice Hall Upper Saddle River, NJ
8. Getzen T. 1997 Health Economics: Fundamentals and Flow of Funds John Wiley and Sons New York, NY
9. Global Forum for Health Research (2002). The 10/90 Report on Health Research 2001-2002. Geneva: Global Forum for Health Research. ISBN 2-940286-07-8. http://www.globalforumhealth.org/pages/index.asp
10. Grier, Holcombe et al. (2003). "Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone." New England Journal of Medicine 348(8), 694-701.
11. J. Henderson 1999 Health Economics and Policy South-Western Publishing Co. Cincinnati, OH
12. IMS Health, http://www.ims-global.com/.
13. Kyle, M. K. (2003). "Product Entry in Global Pharmaceutical Markets: A Cross-National Study." Unpublished paper, Carnegie-Mellon University.
14. Lichtenberg, F. (1996). "Do (More and Better) Drugs Keep People Out of Hospitals?" American Economic Review 86, 384-388.
15. Lichtenberg, F. (2001). "Are the Benefits of Newer Drugs Worth Their Cost? Evidence from the 1996 MEPS." Health Affairs 20(5), 241-251.
16. Liu, Jin-Tan, James K. Hammitt, and Jin-Long Liu (1997). "Estimated Hedonic Wage Function and the Value of Life in a Developing Country." Economics Letters 57, 353-358.
17. K. M. Murphy R. H. Topel 2003 "The Economic Value of Medical Research." In Kevin M. Murphy Robert H. Topel (eds.) Measuring the Gains from Medical Research: An Economic Approach University of Chicago Press Chicago
18. Nordhaus W. 2003 "The Health of Nations: The Contribution of Improved Health to Living Standards." In Kevin M. Murphy Robert H. Topel (Eds) Measuring the Gains from Medical Research: An Economic Approach University of Chicago Press Chicago
19. OECD Health Database. http://www.credes.fr/english/ecosante/oecd.htm.
20. Romer, Paul (1990). "Endogenous Technical Change." Journal of Political Economy 98, S71-S102.
21. R. Santerre S. Neun 2000 Health Economics: Theories, Insights, and Industry Studies revised edition Dryden Press Orlando, FL
22. Simon, N. B., M. L. Cropper, A. Alberini, and S. Arora (1999). "Valuing Mortality Reductions in India: A Study of Compensating-Wage Differentials." World Bank Working Paper Series #2078, March.
23. Stenestrand, U. et al. (2001). "Early Statin Treatment Following Acute Myocardial Infarction and 1-year Survival," Journal of the American Medical Association 285(4), 430-436.
24. United Nations, World Population Prospects Population Database, http://esa.un.org/unpp/index.asp?panel=2.
25. U.S. Pharmacist (2002). "Cancer News," Vol. 27(11), posted November 15, http://www.uspharmacist.com/index.asp?show=article&page=8_999.htm
26. World Health Organization, WHO Mortality Database, http://www3.who.int/whosis/whsa/ftp/download.htm.